Inventor · disambiguated record
Barry J. Simon
Also filed as: SIMON BARRY · SIMON BARRY J · SIMON M D BARRY J
16 granted patents·15 pending applications·62 citations·filing 2012–2025
92Inventor score
Top patents by PatentIndex Score
31 records- 0197US11207350B2Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancerNANTKWEST INC·Filed 2021·Granted Dec 28, 2021·11 cites·11 claims
- 0297US11000550B2Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancerNANTKWEST INC·Filed 2020·Granted May 11, 2021·6 cites·9 claims
- 0395US12384852B2Genetically modified NK-92 cells having a safety switchIMMUNITYBIO INC·Filed 2021·Granted Aug 12, 2025·2 cites·20 claims
- 0495US10456420B2Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancerNANTKWEST INC·Filed 2016·Granted Oct 29, 2019·19 cites·11 claims
- 0593US11207392B2Coordinated multi-prong cancer therapyNANT HOLDINGS IP LLC·Filed 2017·Granted Dec 28, 2021·5 cites·15 claims
- 0693US10736921B2Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancerNANTKWEST INC·Filed 2019·Granted Aug 11, 2020·5 cites·12 claims
- 0792US2024366674A1Tumoricidal and antimicrobial compositions and methodsIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 0891US10517895B2Tumoricidal and antimicrobial compositions and methodsNANTKWEST INC·Filed 2019·Granted Dec 31, 2019·5 cites·20 claims
- 0991US10258649B2Tumoricidal and antimicrobial compositions and methodsNANTKWEST INC·Filed 2014·Granted Apr 16, 2019·9 cites·17 claims
- 1088US2025340664A1Genetically modified nk-92 cell lineIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1183US12064450B2Tumoricidal and antimicrobial compositions and methodsIMMUNITYBIO INC·Filed 2022·Granted Aug 20, 2024·0 cites·11 claims
- 1282US11975027B2Tumoricidal and antimicrobial compositions and methodsIMMUNITYBIO INC·Filed 2021·Granted May 7, 2024·0 cites·8 claims
- 1378US2025170181A1Tumoricidal and antimicrobial compositions and methodsIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1477US10646516B2Tumoricidal and antimicrobial compositions and methodsNANTKWEST INC·Filed 2018·Granted May 12, 2020·0 cites·18 claims
- 1575US11439697B2Nant cancer vaccineNANTCELL INC·Filed 2021·Granted Sep 13, 2022·0 cites·20 claims
- 1674US11304977B2Tumoricidal and antimicrobial compositions and methodsNANTKWEST INC·Filed 2019·Granted Apr 19, 2022·0 cites·5 claims
- 1770US11213547B2Tumoricidal and antimicrobial compositions and methodsNANTKWEST INC·Filed 2019·Granted Jan 4, 2022·0 cites·17 claims
- 1870US10772912B2Tumoricidal and antimicrobial compositionNANTKWEST INC·Filed 2019·Granted Sep 15, 2020·0 cites·15 claims
- 1962US2023034802A1Nant Cancer VaccineNANTCELL INC·Filed 2022·Application pending·0 cites
- 2060US2023381313A1CD16high CD57high NK-92MI CellsIMMUNITYBIO INC·Filed 2023·Application pending·0 cites
- 2158US2024042023A1Fc-Receptor CAR Constructs and CellsIMMUNITYBIO INC·Filed 2021·Application pending·0 cites
- 2256US11221328B2Hypoxic NK cells and methods thereforNANTCELL INC·Filed 2018·Granted Jan 11, 2022·0 cites·4 claims
- 2353US2025298030A1Compositions and Methods for NK-92 Cells Expressing Native CD16IMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 2451US2023172982A1Elimination of BCMA-positive malignancies by CAR expressing NK cellsIMMUNITYBIO INC·Filed 2020·Application pending·0 cites
- 2546US2016244716A1Protocol and media for storage and transport of nk-92 cell lineKLINGEMANN HANS G·Filed 2014·Application pending·0 cites
- 2644US2019192064A1Micro-device and system for determining physiological condition of cervical tissueMB DEVICE LLC·Filed 2019·Application pending·0 cites
- 2743US2022265716A1Antibody pre-loaded cd16+nk-92 cells as an effective therapeutic product for tumor lysisNANTKWEST INC·Filed 2020·Application pending·0 cites
- 2841US2017035347A1Method for monitoring pregnancy in mammalsMB DEVICE LLC·Filed 2016·Application pending·0 cites
- 2940US2014073879A1System for monitoring pregnancy in mammalsCANTOR DIVYA·Filed 2012·Application pending·0 cites
- 3039US2017246209A1Treating viral hemorrhagic fever with nk-92 cellsLEE TIEN·Filed 2015·Application pending·0 cites
- 3137US2017304364A1Nk-92 cells in combination therapy with cancer drugsNANTKWEST INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barry J. Simon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →